Contrast

Contact

Share

Donate

MyChart

Help

Yale New Haven Health names Steven Choi, MD as chief quality officer

Thursday, September 20, 2018



New Haven, CT (Sept. 20, 2018) – Yale New Haven Health (YNHHS) and Yale Medicine have named Steven Choi, MD to serve as their inaugural chief quality officer. In this new role, Dr. Choi will be responsible for developing and overseeing the implementation of a common safety and quality agenda across all inpatient and ambulatory Yale Medicine and Yale New Haven Health sites.

Dr. Choi previously served as the Montefiore Health System assistant vice president, Montefiore Network Performance improvement director and Montefiore Institute for Performance Improvement executive director. Dr. Choi was instrumental in the development of an integrated performance improvement plan for the health system and improved performance against publicly reported quality indicators.

“Dr. Steven Choi brings a wealth of experience and expertise to Yale New Haven Health and Yale Medicine,” said Thomas Balcezak, MD, chief medical officer, YNHHS. “Health systems across the country work harder, closer and more intently than ever to understand the challenges patients and those that care for them face each day. In this new role, Dr. Choi will work closely with the local delivery networks, the YNHHS chief medical officer, medical directors as well as other safety and quality leaders to ensure the successful execution of our unified safety and quality vision.”

Dr. Choi obtained his medical degree from Robert Wood Johnson Medical School, completed pediatric residency training at Columbia University/Babies and Children’s Hospital of New York and a critical care fellowship at University of Southern California School of Medicine/Children’s Hospital Los Angeles.

Dr. Choi lives in Westport with his wife Elizabeth and their three children. He enjoys skiing, paddle boarding, running and is an avid football fan.

Yale New Haven Health (YNHHS), the largest and most comprehensive healthcare system in Connecticut, is recognized for advanced clinical care, quality, service, cost effectiveness and commitment to improving the health status of the communities it serves. YNHHS includes five hospitals – Bridgeport, Greenwich, Lawrence + Memorial, Westerly and Yale New Haven hospitals, several specialty networks and Northeast Medical Group, a non-profit medical foundation with several hundred community-based and hospital-employed physicians. YNHHS is affiliated with Yale University and Yale Medicine, the clinical practice of the Yale School of Medicine and the largest academic multi-specialty practice in New England. Yale New Haven Hospital is the primary teaching hospital of Yale School of Medicine. www.ynhhs.org

Yale Medicine (YM) is the clinical practice of the Yale School of Medicine, with more than 1,400 physicians delivering advanced care in over 100 specialties and subspecialties. All YM physicians are on the faculty of the world-renowned Yale School of Medicine. As one of the largest academic multispecialty practices in New England, YM delivers exceptional medical care in a nurturing, patient-centric environment. The practice has centers of excellence in such fields as cancer, cardiac care, minimally invasive surgery, and organ transplantation. For more information, or to find a doctor, visit www.yalemedicine.org.

Similar Articles

9/15/2021

Marna Borgstrom to retire in 2022 as CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – After more than 43 years of exceptional service, Marna P. Borgstom has announced her intent to retire as chief executive officer of Yale New Haven Health. Her retirement is effective on March 25 2022.

9/15/2021

Christopher O’Connor to become CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – Christopher O’Connor has been named the CEO of Yale New Haven Health (YNHHS), effective March 25, 2022 when current CEO Marna P. Borgstrom retires, announced Vince Calarco, Chair of the YNHHS Board of Trustees. O’Connor currently serves as president of the Health System having been named to that position in August of 2020.

9/1/2021

Outpatient Monoclonal Antibody Treatment decreases hospitalization risk in COVID-19 patients

New Haven, CT (September 1, 2021) – While not a new treatment, monoclonal antibody therapy is being administered more regularly and effectively to patients with mild to moderate COVID-19 with excellent results.